-
Perifosine (KRX-0401): Assays and Workflows
2026-09-24
Perifosine offers a practical way to perturb Akt signaling in cancer-cell viability, apoptosis, and radiation-response experiments. This guide turns its reported activity into a controlled workflow—and distinguishes those oncology applications from the very different, early-stage stroke findings involving Akt/mTOR signaling.
-
Salvianolic Acid B, LH2, and Pulmonary Fibrosis
2026-09-24
The reference study connects elevated lysyl hydroxylase 2 (LH2) with collagen remodeling in pulmonary fibrosis and reports that Salvianolic acid B reduces LH2 expression alongside fibrotic features. Its value is a mechanism-led framework for testing collagen cross-linking, epithelial and fibroblast state changes, and Wnt/β-catenin signaling—not proof that the compound directly binds LH2 or is an established treatment.
-
SB525334 Workflows for TGF-beta1 Signaling
2026-09-23
Learn how to use SB525334 to isolate ALK5-dependent TGF-beta signaling in fibrosis, renal disease, and wound-healing assays. This practical guide connects Smad2/3 phosphorylation inhibition with the bone-transport findings reported in diabetic foot ulcer research.
-
Mechanism-Ready Western Blotting in Atherosclerosis
2026-09-22
A translational framework for connecting the octanal–Olfr2–calcium–ROS–NHE1 axis with more reproducible Western blot evidence, including strategic guidance on secondary antibody dilution, assay controls, and product selection.
-
HRP Rabbit Anti-Goat IgG (H+L) Workflow
2026-09-21
Build sensitive, reproducible assays for goat primary antibodies across western blot, ELISA, dot blot, and tissue imaging. This workflow connects localized p21 mRNA–LNP bladder cancer research with practical HRP-based validation strategies, including assay selection, optimization, and troubleshooting.
-
Ibrexafungerp Workflows for Resistant Candida
2026-09-21
Ibrexafungerp enables research workflows that connect glucan-synthase inhibition with resistant Candida profiling, acidic-pH testing, and translational infection models. Its distinct binding behavior from echinocandins makes MK 3118 especially useful for mapping genotype–phenotype relationships rather than assuming universal cross-resistance.
-
Defactinib: FAK Biology for Translational Research
2026-09-20
A mechanistic and strategic guide to using Defactinib as a FAK phosphorylation inhibitor, linking FAK Tyr397 biology, ovarian cancer research, paclitaxel combinations, and phosphoproteomic thinking without overstating cross-domain evidence.
-
Salvianolic acid B: LH2 Assay Workflow
2026-09-19
Build a matrix-first pulmonary fibrosis workflow around Salvianolic acid B, connecting LH2 expression with collagen remodeling, EMT, and fibroblast activation. Practical handling guidance, orthogonal readouts, and troubleshooting steps help distinguish a genuine antifibrotic response from formulation, viability, or assay-interference artifacts.
-
Erlotinib (NSC 718781) EGFR Assay Workflows
2026-09-19
Use Erlotinib (NSC 718781) to connect EGFR kinase inhibition with phospho-signaling, proliferation, and apoptosis outcomes. This workflow also shows how to position the compound alongside NanoBRET and proximity ligation assays when receptor crosstalk, including CXCR4–EGFR signaling, is the biological question.
-
FGFR1 as a Druggable Target in Schizophrenia
2026-09-18
The reference study integrates drug-target Mendelian randomization, colocalization, SMR validation, phenome-wide association analysis, molecular docking, and single-cell expression data to identify schizophrenia-relevant therapeutic targets. FGFR1 emerged as the most promising candidate, although the findings remain a genetically informed and computationally supported basis for validation rather than evidence of clinical efficacy.
-
Phytol as a Translational RXR Signaling Tool
2026-09-18
Phytol is more than a catalog reagent: it is a context-sensitive probe for retinoid X receptor signaling, PPARα-linked metabolism, and GABAergic transmission modulation. This thought-leadership guide connects mechanistic assay design with translational strategy while using polymer self-assembly research to illustrate why controlled composition, solvent, and identity variables matter.
-
Biotin-tyramide: Practical TSA Workflow Guide
2026-09-17
Biotin-tyramide is a biotinylation reagent for HRP-based tyramide signal amplification in fixed-cell and tissue workflows, including immunohistochemistry and in situ hybridization. It should be handled as a water-insoluble research reagent, not as a diagnostic product or a direct substitute for other biotin phenol formulations.
-
NIH/3T3 Cells: Recovery, Culture, and QC
2026-09-17
NIH/3T3 Cells (BC1017) provide a cryopreserved, adherent mouse fibroblast starting material for controlled culture, cell transfection studies, viral proliferation research, and oncogene research. This guide translates the product dossier into an executable workflow while defining limits: the cells are for research use only and do not establish clinical utility, viral permissiveness, or quantitative assay performance.
-
Procainamide–Cisplatin in Pregnant Mice
2026-09-16
The reference study evaluated whether procainamide hydrochloride could protect pregnant mice from cisplatin toxicity without increasing embryotoxic risk. Its central finding was that co-treatment did not worsen the measured developmental toxicity and modestly improved selected fetal outcomes, possibly through reduced fetal cisplatin accumulation and protection of the dam.
-
PBS Liposomes: Controls for Translational Rigor
2026-09-15
Mechanistic controls determine whether macrophage depletion results reflect clodronate biology or simply liposome exposure. This thought-leadership guide connects lessons from TRPM3 structural pharmacology with practical strategies for using PBS Liposomes in rigorous translational studies.